Skip to main content
Clinical Tools

Risk Stratification

Classifies BCC and SCC into high- and low-risk tiers using NCCN v1.2026 criteria. Evaluates tumor size, location, subtype, and clinical features to determine Mohs indication and workup recommendations.

Privacy: All calculations are performed locally in your browser. No patient data is transmitted, stored, or shared.

This platform is not a HIPAA Business Associate. Do not enter identifiable patient information.

References

  1. National Comprehensive Cancer Network (NCCN). Basal Cell Skin Cancer. NCCN Clinical Practice Guidelines in Oncology. Version 1.2026.
  2. National Comprehensive Cancer Network (NCCN). Squamous Cell Skin Cancer. NCCN Clinical Practice Guidelines in Oncology. Version 1.2026.
  3. Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery. J Am Acad Dermatol. 2012;67(4):531-550.

For clinical decision support only. Risk classification is based on NCCN criteria and should be used in conjunction with clinical judgment. This tool does not replace specialist consultation or established guidelines.

By Dr. Yehonatan Kaplan · Kaplan Clinic